Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Lung Cancer

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 194 articles: HTML format

Single Articles

June 2008
1. PEACOCK CD , Watkins DN
   Cancer stem cells and the ontogeny of lung cancer.
   J Clin Oncol. 2008;26:2883-9.
   PubMed     Related articles    Abstract available
   
   
   
2. HERTH FJ , Annema JT, Eberhardt R, Yasufuku K, et al
   Endobronchial Ultrasound With Transbronchial Needle Aspiration for Restaging the Mediastinum in Lung Cancer.
   J Clin Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. PASS HI
   Lung Cancer Staging Techniques and Induction Therapy: Maybe Timing Is Everything.
   J Clin Oncol. 2008;.
   PubMed     Related articles   
   
   
   
4. YANG CH , Yu CJ, Shih JY, Chang YC, et al
   Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.
   J Clin Oncol. 2008;26:2745-53.
   PubMed     Related articles    Abstract available
   
   
   May 2008
5. SCAGLIOTTI GV , Parikh P, von Pawel J, Biesma B, et al
   Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. EINHORN LH
   First-Line Chemotherapy for Non-Small-Cell Lung Cancer: Is There a Superior Regimen Based on Histology?
   J Clin Oncol. 2008;.
   PubMed     Related articles   
   
   
   
7. SOCINSKI MA , Blackstock AW, Bogart JA, Wang X, et al
   Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.
   J Clin Oncol. 2008;26:2457-63.
   PubMed     Related articles    Abstract available
   
   
   
8. LEE SM , Buchler T, Joseph T, Lai C, et al
   Bilateral eardrum perforation after long-term treatment with erlotinib.
   J Clin Oncol. 2008;26:2582-4.
   PubMed     Related articles   
   
   
   
9. BOUGHANIM M , Leboulleux S, Rey A, Pham CT, et al
   Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
   J Clin Oncol. 2008;26:2558-61.
   PubMed     Related articles    Abstract available
   
   
   
10. KEATING NL , Landrum MB, Klabunde CN, Fletcher RH, et al
    Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
    J Clin Oncol. 2008;26:2532-7.
    PubMed     Related articles    Abstract available
    
    
    
11. WHEATLEY-PRICE P , Ding K, Seymour L, Clark GM, et al
    Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
    J Clin Oncol. 2008;26:2350-7.
    PubMed     Related articles    Abstract available
    
    
    
12. PIRKER R , Ramlau RA, Schuette W, Zatloukal P, et al
    Safety and efficacy of darbepoetin alpha in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide.
    J Clin Oncol. 2008;26:2342-9.
    PubMed     Related articles    Abstract available
    
    
    
13. OBERLIN O , Rey A, Lyden E, Bisogno G, et al
    Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.
    J Clin Oncol. 2008;26:2384-9.
    PubMed     Related articles    Abstract available
    
    
    
14. SHEPHERD FA
    Molecular Selection of Patients for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Epidermal Growth Factor Inhibitors: Not Quite Ready for Prime Time.
    J Clin Oncol. 2008;.
    PubMed     Related articles   
    
    
    
15. SEQUIST LV , Martins RG, Spigel D, Grunberg SM, et al
    First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. LIMA CG JR , Cordova AL Jr
    Is there a definitive answer to the question of involved-field radiotherapy for inoperable non-small-cell lung cancer?
    J Clin Oncol. 2008;26:2235.
    PubMed     Related articles   
    
    
    
17. SAMUEL TA , Subbannan K
    Horns of a dilemma.
    J Clin Oncol. 2008;26:2219-20.
    PubMed     Related articles   
    
    
    
18. CHAO BH , Stogner-Underwood KA, Kiev J, Smith TJ, et al
    Intrathoracic malignant peripheral nerve sheath tumor in neurofibromatosis 1.
    J Clin Oncol. 2008;26:2216-8.
    PubMed     Related articles   
    
    
    
19. CESCON DW , Page AV, Richardson S, Moore MJ, et al
    Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancer.
    J Clin Oncol. 2008;26:2214-5.
    PubMed     Related articles   
    
    
    April 2008
20. ATKINS CD
    Improved survival with addition of bevacizumab to paclitaxel and carboplatin in elderly patients with non-small-cell lung cancer.
    J Clin Oncol. 2008;26:2063-4.
    PubMed     Related articles   
    
    
    
21. PALKA KT , Lebow RL, Weaver KD, Kressin MK, et al
    Intracranial collision metastases of small-cell lung cancer and malignant melanoma.
    J Clin Oncol. 2008;26:2042-6.
    PubMed     Related articles   
    
    
    
22. GOEL S
    Reporting of subset analysis: where do we draw the line?
    J Clin Oncol. 2008;26:2062-3.
    PubMed     Related articles   
    
    
    
23. RAMLAU R , Zatloukal P, Jassem J, Schwarzenberger P, et al
    Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    J Clin Oncol. 2008;26:1886-92.
    PubMed     Related articles    Abstract available
    
    
    
24. BLUMENSCHEIN GR JR , Khuri FR, von Pawel J, Gatzemeier U, et al
    Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.
    J Clin Oncol. 2008;26:1879-85.
    PubMed     Related articles    Abstract available
    
    
    
25. LAURIE SA , Gauthier I, Arnold A, Shepherd FA, et al
    Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institu
    J Clin Oncol. 2008;26:1871-8.
    PubMed     Related articles    Abstract available
    
    
    
26. TRAINA TA , Theodoulou M, Feigin K, Patil S, et al
    Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
    J Clin Oncol. 2008;26:1797-802.
    PubMed     Related articles    Abstract available
    
    
    
27. JEREMIC B , Koning C
    Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again.
    J Clin Oncol. 2008;26:e1-2.
    PubMed     Related articles   
    
    
    March 2008
28. KELLY K , Chansky K, Gaspar LE, Albain KS, et al
    Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non-Small-Cell Lung Cancer: SWOG S0023.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. KEEDY VL , Arteaga CL, Johnson DH
    Does Gefitinib Shorten Lung Cancer Survival? Chaos Redux.
    J Clin Oncol. 2008;.
    PubMed     Related articles   
    
    
    
30. MILLER VA , Riely GJ, Zakowski MF, Li AR, et al
    Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
    J Clin Oncol. 2008;26:1472-8.
    PubMed     Related articles    Abstract available
    
    
    
31. HOANG JK , Hoagland LF, Coleman RE, Coan AD, et al
    Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
    J Clin Oncol. 2008;26:1459-64.
    PubMed     Related articles    Abstract available
    
    
    
32. NENINGER VINAGERAS E , de la Torre A, Osorio Rodriguez M, Catala Ferrer M, et al
    Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer.
    J Clin Oncol. 2008;26:1452-8.
    PubMed     Related articles    Abstract available
    
    
    
33. NEMUNAITIS JJ
    Are vaccines making a comeback in non-small-cell lung cancer?
    J Clin Oncol. 2008;26:1402-3.
    PubMed     Related articles   
    
    
    
34. PANT S , Landon MB, Blumenfeld M, Farrar W, et al
    Treatment of breast cancer with trastuzumab during pregnancy.
    J Clin Oncol. 2008;26:1567-9.
    PubMed     Related articles   
    
    
    
35. LIEUW-A-FA M , Peringa J, Leeksma O, Terpstra W, et al
    Sepsis from liver abscesses in metastatic colorectal carcinoma after chemoimmunotherapy.
    J Clin Oncol. 2008;26:1381-2.
    PubMed     Related articles   
    
    
    
36. WITTELES WH , Schrier SL, Wakelee HA
    Lung cancer presenting with amegakaryocytic thrombocytopenia.
    J Clin Oncol. 2008;26:1171-4.
    PubMed     Related articles   
    
    
    
37. TANVETYANON T , Robinson LA, Schell MJ, Strong VE, et al
    Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.
    J Clin Oncol. 2008;26:1142-7.
    PubMed     Related articles    Abstract available
    
    
    
38. OH Y , Herbst RS, Burris H, Cleverly A, et al
    Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancer.
    J Clin Oncol. 2008;26:1135-41.
    PubMed     Related articles    Abstract available
    
    
    
39. DOOMS C , Verbeken E, Stroobants S, Nackaerts K, et al
    Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose p
    J Clin Oncol. 2008;26:1128-34.
    PubMed     Related articles    Abstract available
    
    
    
40. DE PALMA R , Liberati A, Ciccone G, Bandieri E, et al
    Developing clinical recommendations for breast, colorectal, and lung cancer adjuvant treatments using the GRADE system: a study from the Programma Ricerca e Innovazione Emilia Romagna Oncology Research Group.
    J Clin Oncol. 2008;26:1033-9.
    PubMed     Related articles    Abstract available
    
    
    
41. COSTA DB , Schumer ST, Tenen DG, Kobayashi S, et al
    Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations.
    J Clin Oncol. 2008;26:1182-4.
    PubMed     Related articles   
    
    
    
42. ANKER CJ , Dechet C, Isaac JC, Akerley W, et al
    Small-cell carcinoma of the prostate.
    J Clin Oncol. 2008;26:1168-71.
    PubMed     Related articles   
    
    
    
43. RUDIN CM , Liu W, Desai A, Karrison T, et al
    Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
    J Clin Oncol. 2008;26:1119-27.
    PubMed     Related articles    Abstract available
    
    
    
44. BROUWERS MC , Somerfield MR, Browman GP
    A for effort: learning from the application of the GRADE approach to cancer guideline development.
    J Clin Oncol. 2008;26:1025-6.
    PubMed     Related articles   
    
    
    February 2008
45. SOSVINSKA-MIELCAREK K , Senkus-Konefka E, Jassem J, Kulczycka J, et al
    Cardiac involvement at presentation of non-small-cell lung cancer.
    J Clin Oncol. 2008;26:1010-1.
    PubMed     Related articles   
    
    
    
46. EBERHARD DA , Giaccone G, Johnson BE
    Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.
    J Clin Oncol. 2008;26:983-94.
    PubMed     Related articles    Abstract available
    
    
    
47. SUN Z , Wigle DA, Yang P
    Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
    J Clin Oncol. 2008;26:877-83.
    PubMed     Related articles    Abstract available
    
    
    
48. RUDIN CM , Salgia R, Wang X, Hodgson LD, et al
    Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
    J Clin Oncol. 2008;26:870-6.
    PubMed     Related articles    Abstract available
    
    
    
49. LILENBAUM R , Axelrod R, Thomas S, Dowlati A, et al
    Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.
    J Clin Oncol. 2008;26:863-9.
    PubMed     Related articles    Abstract available
    
    
    
50. HEIST RS , Zhai R, Liu G, Zhou W, et al
    VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
    J Clin Oncol. 2008;26:856-62.
    PubMed     Related articles    Abstract available
    
    
    
51. EDELMAN MJ , Watson D, Wang X, Morrison C, et al
    Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--cancer and leukemia group B trial 30203.
    J Clin Oncol. 2008;26:848-55.
    PubMed     Related articles    Abstract available
    
    
    
52. BACKLUND MG , Amann JM, Johnson DH
    Novel strategies for the treatment of lung cancer: modulation of eicosanoids.
    J Clin Oncol. 2008;26:825-7.
    PubMed     Related articles   
    
    
    
53. WHEATER MJ , Mead GM, Bhandari S, Fennell J, et al
    Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma.
    J Clin Oncol. 2008;26:1008-10.
    PubMed     Related articles   
    
    
    
54. SOCINSKI MA , Novello S, Brahmer JR, Rosell R, et al
    Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.
    J Clin Oncol. 2008;26:650-6.
    PubMed     Related articles    Abstract available
    
    
    
55. RIZVI NA , Riely GJ, Azzoli CG, Miller VA, et al
    Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
    J Clin Oncol. 2008;26:639-43.
    PubMed     Related articles    Abstract available
    
    
    
56. COSTA DB , Kobayashi S
    Response of intracranial metastases to epidermal growth factor receptor tyrosine kinase inhibitors: it may all depend on EGFR mutations.
    J Clin Oncol. 2008;26:686.
    PubMed     Related articles   
    
    
    
57. VELICER CM , Ulrich CM
    Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review.
    J Clin Oncol. 2008;26:665-73.
    PubMed     Related articles    Abstract available
    
    
    
58. KUNITOH H , Kato H, Tsuboi M, Shibata T, et al
    Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.
    J Clin Oncol. 2008;26:644-9.
    PubMed     Related articles    Abstract available
    
    
    
59. MEYERS PA , Schwartz CL, Krailo MD, Healey JH, et al
    Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    J Clin Oncol. 2008;26:633-8.
    PubMed     Related articles    Abstract available
    
    
    January 2008
60. BELANI CP , Ramalingam S, Perry MC, LaRocca RV, et al
    Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
    J Clin Oncol. 2008;26:468-73.
    PubMed     Related articles    Abstract available
    
    
    
61. LARA PN JR , Redman MW, Kelly K, Edelman MJ, et al
    Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials.
    J Clin Oncol. 2008;26:463-7.
    PubMed     Related articles    Abstract available
    
    
    
62. KAUFMAN EL , Jacobson JS, Hershman DL, Desai M, et al
    Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
    J Clin Oncol. 2008;26:392-8.
    PubMed     Related articles    Abstract available
    
    
    
63. GABRIJEL S , Grize L, Helfenstein E, Brutsche M, et al
    Receiving the diagnosis of lung cancer: patient recall of information and satisfaction with physician communication.
    J Clin Oncol. 2008;26:297-302.
    PubMed     Related articles    Abstract available
    
    
    
64. TIMMER-BONTE JN , Adang EM, Termeer E, Severens JL, et al
    Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
    J Clin Oncol. 2008;26:290-6.
    PubMed     Related articles    Abstract available
    
    
    
65. GRALOW J , Ozols RF, Bajorin DF, Cheson BD, et al
    Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    J Clin Oncol. 2008;26:313-25.
    PubMed     Related articles    Abstract available
    
    
    
66. ROSSI A , Gridelli C, Bria E
    Thalidomide in small-cell lung cancer: is it a tombstone?
    J Clin Oncol. 2008;26:160.
    PubMed     Related articles   
    
    
    
67. RAMALINGAM SS , Dahlberg SE, Langer CJ, Gray R, et al
    Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.
    J Clin Oncol. 2008;26:60-5.
    PubMed     Related articles    Abstract available
    
    
    
68. ASMIS TR , Ding K, Seymour L, Shepherd FA, et al
    Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    J Clin Oncol. 2008;26:54-9.
    PubMed     Related articles    Abstract available
    
    
    
69. GRIDELLI C
    Treatment of advanced non small-cell lung cancer in the elderly: from best supportive care to the combination of platin-based chemotherapy and targeted therapies.
    J Clin Oncol. 2008;26:13-5.
    PubMed     Related articles   
    
    
    December 2007
70. ARTAC M , Bozcuk H
    The debate about maintenance is not over in small-cell lung cancer.
    J Clin Oncol. 2007;25:5840.
    PubMed     Related articles   
    
    
    
71. SCHWARTZ AG , Wenzlaff AS, Prysak GM, Murphy V, et al
    Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    J Clin Oncol. 2007;25:5785-92.
    PubMed     Related articles    Abstract available
    
    
    
72. BUTTS CA , Bodkin D, Middleman EL, Englund CW, et al
    Randomized phase II study of gemcitabine plus cisplatin, with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.
    J Clin Oncol. 2007;25:5777-84.
    PubMed     Related articles    Abstract available
    
    
    
73. SCHNOLL RA , Wileyto EP, Hornik R, Schiller J, et al
    Spiral computed tomography and lung cancer: science, the media, and public opinion.
    J Clin Oncol. 2007;25:5695-7.
    PubMed     Related articles   
    
    
    
74. LEE HC , Chu CY, Hsiao CH
    Carcinoma erysipeloides from ovarian clear-cell carcinoma.
    J Clin Oncol. 2007;25:5828-30.
    PubMed     Related articles   
    
    
    
75. KENNY PM , King MT, Viney RC, Boyer MJ, et al
    Quality of Life and Survival in the 2 Years After Surgery for Non Small-Cell Lung Cancer.
    J Clin Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. PATZ EF JR , Campa MJ, Gottlin EB, Kusmartseva I, et al
    Panel of serum biomarkers for the diagnosis of lung cancer.
    J Clin Oncol. 2007;25:5578-83.
    PubMed     Related articles    Abstract available
    
    
    
77. OWONIKOKO TK , Ragin CC, Belani CP, Oton AB, et al
    Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.
    J Clin Oncol. 2007;25:5570-7.
    PubMed     Related articles    Abstract available
    
    
    
78. LAU SK , Boutros PC, Pintilie M, Blackhall FH, et al
    Three-gene prognostic classifier for early-stage non small-cell lung cancer.
    J Clin Oncol. 2007;25:5562-9.
    PubMed     Related articles    Abstract available
    
    
    
79. VAN RENTERGHEM D
    Lung cancer survival: vitamin d could be just a marker of physical fitness.
    J Clin Oncol. 2007;25:5537-8.
    PubMed     Related articles   
    
    
    
80. TISHELMAN C , Petersson LM, Degner LF, Sprangers MA, et al
    Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death.
    J Clin Oncol. 2007;25:5381-9.
    PubMed     Related articles    Abstract available
    
    
    
81. VOLKER T , Denecke T, Steffen I, Misch D, et al
    Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
    J Clin Oncol. 2007;25:5435-41.
    PubMed     Related articles    Abstract available
    
    
    
82. BASCH E , Iasonos A, Barz A, Culkin A, et al
    Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy.
    J Clin Oncol. 2007;25:5374-80.
    PubMed     Related articles    Abstract available
    
    
    November 2007
83. TSAO MS , Aviel-Ronen S, Ding K, Lau D, et al
    Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.
    J Clin Oncol. 2007;25:5240-7.
    PubMed     Related articles    Abstract available
    
    
    
84. PARK JO , Kim SW, Ahn JS, Suh C, et al
    Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.
    J Clin Oncol. 2007;25:5233-9.
    PubMed     Related articles    Abstract available
    
    
    
85. SOCINSKI MA , Stinchcombe TE
    Duration of first-line chemotherapy in advanced non small-cell lung cancer: less is more in the era of effective subsequent therapies.
    J Clin Oncol. 2007;25:5155-7.
    PubMed     Related articles   
    
    
    
86. GLYNNE-JONES R , Hoskin P
    Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?
    J Clin Oncol. 2007;25:5281-6.
    PubMed     Related articles    Abstract available
    
    
    
87. CRUMP M , Gluck S, Tu D, Stewart D, et al
    Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16.
    J Clin Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. ROSENZWEIG KE , Sura S, Jackson A, Yorke E, et al
    Involved-Field Radiation Therapy for Inoperable Non Small-Cell Lung Cancer.
    J Clin Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. JEREMIC B
    Low Incidence of Isolated Nodal Failures After Involved-Field Radiation Therapy for Non Small-Cell Lung Cancer: Blinded by the Light?
    J Clin Oncol. 2007;.
    PubMed     Related articles   
    
    
    
90. POTTGEN C , Eberhardt W, Grannass A, Korfee S, et al
    Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.
    J Clin Oncol. 2007;25:4987-92.
    PubMed     Related articles    Abstract available
    
    
    
91. FEKRAZAD MH , Ravindranathan M, Jones DV Jr
    Response of intracranial metastases to erlotinib therapy.
    J Clin Oncol. 2007;25:5024-6.
    PubMed     Related articles   
    
    
    
92. SWANSON SJ , Herndon JE 2nd, D'Amico TA, Demmy TL, et al
    Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study.
    J Clin Oncol. 2007;25:4993-7.
    PubMed     Related articles    Abstract available
    
    
    October 2007
93. PISTER KM , Evans WK, Azzoli CG, Kris MG, et al
    Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small-Cell Lung Cancer Guideline.
    J Clin Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. GARRIDO P , Gonzalez-Larriba JL, Insa A, Provencio M, et al
    Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901.
    J Clin Oncol. 2007;25:4736-42.
    PubMed     Related articles    Abstract available
    
    
    
95. SALTZ LB , Rosen LS, Marshall JL, Belt RJ, et al
    Phase II Trial of Sunitinib in Patients With Metastatic Colorectal Cancer After Failure of Standard Therapy.
    J Clin Oncol. 2007;25:4793-9.
    PubMed     Related articles    Abstract available
    
    
    
96. GRIDELLI C , Maione P, Illiano A, Piantedosi FV, et al
    Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.
    J Clin Oncol. 2007;25:4663-9.
    PubMed     Related articles    Abstract available
    
    
    
97. GERBER PA , Enderlein E, Homey B, Muller A, et al
    Radiation-induced prevention of erlotinib-induced skin rash is transient: a new aspect toward the understanding of epidermal growth factor receptor inhibitor associated cutaneous adverse effects.
    J Clin Oncol. 2007;25:4697-8.
    PubMed     Related articles   
    
    
    
98. HERBST RS , O'neill VJ, Fehrenbacher L, Belani CP, et al
    Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Chemotherapy or Erlotinib Compared With Chemotherapy Alone for Treatment of Recurrent or Refractory Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. BARLESI F , Giaccone G, Gallegos-Ruiz MI, Loundou A, et al
    Global histone modifications predict prognosis of resected non small-cell lung cancer.
    J Clin Oncol. 2007;25:4358-64.
    PubMed     Related articles    Abstract available
    
    
    
100. HSU DS , Balakumaran BS, Acharya CR, Vlahovic V, et al
     Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.
     J Clin Oncol. 2007;25:4350-7.
     PubMed     Related articles    Abstract available
     
     
     September 2007
101. GRADILONE A , Pulcinelli FM, Lotti LV, Martino S, et al
     Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications.
     J Clin Oncol. 2007;25:4318-20.
     PubMed     Related articles   
     
     
     
102. ARNOLD AM , Seymour L, Smylie M, Ding K, et al
     Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.
     J Clin Oncol. 2007;25:4278-84.
     PubMed     Related articles    Abstract available
     
     
     
103. HEYMACH JV , Johnson BE, Prager D, Csada E, et al
     Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer.
     J Clin Oncol. 2007;25:4270-7.
     PubMed     Related articles    Abstract available
     
     
     
104. BLACKSTOCK AW , Govindan R
     Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer.
     J Clin Oncol. 2007;25:4146-52.
     PubMed     Related articles    Abstract available
     
     
     
105. SOCINSKI MA , Bogart JA
     Limited-stage small-cell lung cancer: the current status of combined-modality therapy.
     J Clin Oncol. 2007;25:4137-45.
     PubMed     Related articles    Abstract available
     
     
     
106. PUJOL JL , Breton JL, Gervais R, Tanguy ML, et al
     Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01.
     J Clin Oncol. 2007;25:3945-51.
     PubMed     Related articles    Abstract available
     
     
     
107. JANNE PA , von Pawel J, Cohen RB, Crino L, et al
     Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.
     J Clin Oncol. 2007;25:3936-44.
     PubMed     Related articles    Abstract available
     
     
     
108. SUEHISA H , Toyooka S, Hotta K, Uchida A, et al
     Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
     J Clin Oncol. 2007;25:3952-7.
     PubMed     Related articles    Abstract available
     
     
     August 2007
109. SOON WONG N , Seong Ooi W, Pritchard KI
     Role of gonadotropin-releasing hormone analog in the management of male metastatic breast cancer is uncertain.
     J Clin Oncol. 2007;25:3787.
     PubMed     Related articles   
     
     
     
110. GIANNI L
     Ixabepilone and the narrow path to developing new cytotoxic drugs.
     J Clin Oncol. 2007;25:3389-91.
     PubMed     Related articles   
     
     
     
111. O'BYRNE KJ , Danson S, Dunlop D, Botwood N, et al
     Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non small-cell lung cancer.
     J Clin Oncol. 2007;25:3266-73.
     PubMed     Related articles    Abstract available
     
     
     July 2007
112. SCHILD SE , Bonner JA, Hillman S, Kozelsky TF, et al
     Results of a Phase II Study of High-Dose Thoracic Radiation Therapy With Concurrent Cisplatin and Etoposide in Limited-Stage Small-Cell Lung Cancer (NCCTG 95-20-53).
     J Clin Oncol. 2007;25:3124-9.
     PubMed     Related articles    Abstract available
     
     
     
113. KONG FM , Frey KA, Quint LE, Haken RK, et al
     A Pilot Study of [18F]Fluorodeoxyglucose Positron Emission Tomography Scans During and After Radiation-Based Therapy in Patients With Non Small-Cell Lung Cancer.
     J Clin Oncol. 2007;25:3116-23.
     PubMed     Related articles    Abstract available
     
     
     
114. VANSTEENKISTE J , Lara PN Jr, Le Chevalier T, Breton JL, et al
     Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non-Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
115. COBO M , Isla D, Massuti B, Montes A, et al
     Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer.
     J Clin Oncol. 2007;25:2747-54.
     PubMed     Related articles    Abstract available
     
     
     
116. SIMON G , Sharma A, Li X, Hazelton T, et al
     Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
     J Clin Oncol. 2007;25:2741-6.
     PubMed     Related articles    Abstract available
     
     
     
117. FILIPITS M , Pirker R, Dunant A, Lantuejoul S, et al
     Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
     J Clin Oncol. 2007;25:2735-40.
     PubMed     Related articles    Abstract available
     
     
     
118. BOLONAKI I , Kotsakis A, Papadimitraki E, Aggouraki D, et al
     Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
     J Clin Oncol. 2007;25:2727-34.
     PubMed     Related articles    Abstract available
     
     
     
119. SORIA JC
     ERCC1-tailored chemotherapy in lung cancer: the first prospective randomized trial.
     J Clin Oncol. 2007;25:2648-9.
     PubMed     Related articles   
     
     
     
120. LONGO R , Torino F, Castellana M, Amici S, et al
     Skin acrometastases in squamous cell carcinoma of the tongue.
     J Clin Oncol. 2007;25:2847-8.
     PubMed     Related articles   
     
     
     
121. BENOWITZ NL
     Cigarette smoking and the personalization of irinotecan therapy.
     J Clin Oncol. 2007;25:2646-7.
     PubMed     Related articles   
     
     
     June 2007
122. BIVALACQUA TJ , Alphs H, Aksentijevich I, Schaeffer EM, et al
     Paraneoplastic polyarthritis from non-small-cell lung cancer metastatic to the bladder.
     J Clin Oncol. 2007;25:2621-3.
     PubMed     Related articles   
     
     
     
123. KARTACHOVA M , van Zandwijk N, Burgers S, van Tinteren H, et al
     Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer.
     J Clin Oncol. 2007;25:2534-9.
     PubMed     Related articles    Abstract available
     
     
     
124. CHO BC , Im CK, Park MS, Kim SK, et al
     Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.
     J Clin Oncol. 2007;25:2528-33.
     PubMed     Related articles    Abstract available
     
     
     
125. LEE MJ , Kim EK, Kim MJ, Kwak JY, et al
     Spontaneous pneumothorax in metastatic thyroid papillary carcinoma.
     J Clin Oncol. 2007;25:2616-8.
     PubMed     Related articles   
     
     
     
126. BUNN PA JR
     Can acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors be overcome by different small-molecule tyrosine kinase inhibitors?
     J Clin Oncol. 2007;25:2504-5.
     PubMed     Related articles   
     
     
     
127. TEMEL JS , Jackson VA, Billings JA, Dahlin C, et al
     Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.
     J Clin Oncol. 2007;25:2377-82.
     PubMed     Related articles    Abstract available
     
     
     
128. MACHENS A , Dralle H
     Bronchoalveolar lavage for diagnosis of miliary lung metastases from papillary thyroid carcinoma.
     J Clin Oncol. 2007;25:2495-6.
     PubMed     Related articles   
     
     
     
129. IRVIN W , MacDonald G, Smith JK, Kim WY, et al
     Dexamethasone-induced posterior reversible encephalopathy syndrome.
     J Clin Oncol. 2007;25:2484-6.
     PubMed     Related articles   
     
     
     
130. NG R , Hasan B, Mittmann N, Florescu M, et al
     Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, N
     J Clin Oncol. 2007;25:2256-61.
     PubMed     Related articles    Abstract available
     
     
     
131. CAPPUZZO F , Ligorio C, Janne PA, Toschi L, et al
     Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial.
     J Clin Oncol. 2007;25:2248-55.
     PubMed     Related articles    Abstract available
     
     
     
132. HEIST RS , Zhou W, Chirieac LR, Cogan-Drew T, et al
     MDM2 polymorphism, survival, and histology in early-stage non-small-cell lung cancer.
     J Clin Oncol. 2007;25:2243-7.
     PubMed     Related articles    Abstract available
     
     
     
133. IURISCI I , Rich T, Levi F, Innominato PF, et al
     Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer.
     J Clin Oncol. 2007;25:e17-9.
     PubMed     Related articles   
     
     
     May 2007
134. LEO F , Solli P, Veronesi G, Catalano G, et al
     Induction chemoradiotherapy for superior sulcus non-small-cell lung cancer: an answer for few.
     J Clin Oncol. 2007;25:2146.
     PubMed     Related articles   
     
     
     
135. ECKARDT JR , von Pawel J, Pujol JL, Papai Z, et al
     Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.
     J Clin Oncol. 2007;25:2086-92.
     PubMed     Related articles    Abstract available
     
     
     
136. RAZ DJ , Jablons DM
     EGFR expression and mutational analysis as a predictive test.
     J Clin Oncol. 2007;25:2144.
     PubMed     Related articles   
     
     
     
137. LACOUTURE ME , Hwang C, Marymont MH, Patel J, et al
     Temporal dependence of the effect of radiation on erlotinib-induced skin rash.
     J Clin Oncol. 2007;25:2140.
     PubMed     Related articles   
     
     
     
138. MARTUSEWICZ-BOROS M , Wiatr E, Radzikowska E, Roszkowski-Sliz K, et al
     Pulmonary intravascular large B-cell lymphoma as a cause of severe hypoxemia.
     J Clin Oncol. 2007;25:2137-9.
     PubMed     Related articles   
     
     
     
139. GRIDELLI C , Langer C, Maione P, Rossi A, et al
     Lung cancer in the elderly.
     J Clin Oncol. 2007;25:1898-907.
     PubMed     Related articles    Abstract available
     
     
     
140. MUSS HB , Biganzoli L, Sargent DJ, Aapro M, et al
     Adjuvant therapy in the elderly: making the right decision.
     J Clin Oncol. 2007;25:1870-5.
     PubMed     Related articles    Abstract available
     
     
     
141. WISNIVESKY JP , Halm EA
     Sex differences in lung cancer survival: do tumors behave differently in elderly women?
     J Clin Oncol. 2007;25:1705-12.
     PubMed     Related articles    Abstract available
     
     
     April 2007
142. STINCHCOMBE TE , Walters R, Khandani AH, Socinksi MA, et al
     Radiation-induced sarcoma after high-dose thoracic radiation therapy in non-small-cell lung cancer.
     J Clin Oncol. 2007;25:1621-3.
     PubMed     Related articles   
     
     
     
143. GATZEMEIER U , Pluzanska A, Szczesna A, Kaukel E, et al
     Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.
     J Clin Oncol. 2007;25:1545-52.
     PubMed     Related articles    Abstract available
     
     
     
144. PEPE C , Hasan B, Winton TL, Seymour L, et al
     Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
     J Clin Oncol. 2007;25:1553-61.
     PubMed     Related articles    Abstract available
     
     
     
145. GIANTONIO BJ , Catalano PJ, Meropol NJ, O'dwyer PJ, et al
     Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
     J Clin Oncol. 2007;25:1539-44.
     PubMed     Related articles    Abstract available
     
     
     
146. GOVINDARAJAN R , Ratnasinghe L, Simmons DL, Siegel ER, et al
     Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.
     J Clin Oncol. 2007;25:1476-81.
     PubMed     Related articles    Abstract available
     
     
     
147. GRIDELLI C , Maione P, Rossi A
     Single-agent chemotherapy for the treatment of elderly patients with advanced non-small-cell lung cancer: what is the best drug?
     J Clin Oncol. 2007;25:1444-5.
     PubMed     Related articles   
     
     
     
148. DI MAIO M , Perrone F, Chiodini P, Gallo C, et al
     Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer.
     J Clin Oncol. 2007;25:1377-82.
     PubMed     Related articles    Abstract available
     
     
     
149. RYAN A , Razak A, Graham J, Benson A, et al
     Desmoplastic small round-cell tumor of the pancreas.
     J Clin Oncol. 2007;25:1440-2.
     PubMed     Related articles   
     
     
     
150. VOKES EE , Herndon Ii JE, Kelley MJ, Cicchetti MG, et al
     Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non-Small-Cell Lung Cancer: Cancer and Leukemia Group B.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     March 2007
151. MALANI AK , Abou-Jawde RM, Singh J, Taylor SA, et al
     Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients.
     J Clin Oncol. 2007;25:1143-4.
     PubMed     Related articles   
     
     
     
152. LIAPI E , Geschwind JF
     Transcatheter and ablative therapeutic approaches for solid malignancies.
     J Clin Oncol. 2007;25:978-86.
     PubMed     Related articles    Abstract available
     
     
     
153. SCHULZ-ERTNER D , Tsujii H
     Particle radiation therapy using proton and heavier ion beams.
     J Clin Oncol. 2007;25:953-64.
     PubMed     Related articles    Abstract available
     
     
     
154. TIMMERMAN RD , Kavanagh BD, Cho LC, Papiez L, et al
     Stereotactic body radiation therapy in multiple organ sites.
     J Clin Oncol. 2007;25:947-52.
     PubMed     Related articles    Abstract available
     
     
     
155. LE PECHOUX C , Dunant A, Pignon JP, De Ruysscher D, et al
     Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with n2 mediastinal involvement.
     J Clin Oncol. 2007;25:e10-1.
     PubMed     Related articles   
     
     
     February 2007
156. WRIGHT JR , Ung YC, Julian JA, Pritchard KI, et al
     Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non-Small-Cell Lung Cancer With Disease-Related Anemia.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
157. SEQUIST LV , Bell DW, Lynch TJ, Haber DA, et al
     Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer.
     J Clin Oncol. 2007;25:587-95.
     PubMed     Related articles    Abstract available
     
     
     
158. SUBRAMANIAN J , Govindan R
     Lung cancer in never smokers: a review.
     J Clin Oncol. 2007;25:561-70.
     PubMed     Related articles    Abstract available
     
     
     
159. ZHOU W , Heist RS, Liu G, Asomaning K, et al
     Circulating 25-hydroxyvitamin d levels predict survival in early-stage non-small-cell lung cancer patients.
     J Clin Oncol. 2007;25:479-85.
     PubMed     Related articles    Abstract available
     
     
     
160. WAKELEE HA , Chang ET, Gomez SL, Keegan TH, et al
     Lung cancer incidence in never smokers.
     J Clin Oncol. 2007;25:472-8.
     PubMed     Related articles    Abstract available
     
     
     
161. GAZDAR AF , Thun MJ
     Lung cancer, smoke exposure, and sex.
     J Clin Oncol. 2007;25:469-71.
     PubMed     Related articles   
     
     
     
162. MIYANO S , Izumi S, Takeda Y, Tokuhara M, et al
     Pulmonary tumor thrombotic microangiopathy.
     J Clin Oncol. 2007;25:597-9.
     PubMed     Related articles   
     
     
     
163. TURRISI A , Keller S
     Since chemotherapy is now the standard in node-positive lung cancer, what is the role of postoperative radiotherapy?
     J Clin Oncol. 2007;25:459-60.
     PubMed     Related articles   
     
     
     
164. LANGER C , Li S, Schiller J, Tester W, et al
     Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 Non-small-cell lung cancer patients: ECOG 1599.
     J Clin Oncol. 2007;25:418-23.
     PubMed     Related articles    Abstract available
     
     
     
165. SENAN S , Haasbeek NJ, Smit EF, Lagerwaard FJ, et al
     Stereotactic radiotherapy for centrally located early-stage lung tumors.
     J Clin Oncol. 2007;25:464.
     PubMed     Related articles   
     
     
     January 2007
166. RUSCH VW , Giroux DJ, Kraut MJ, Crowley J, et al
     Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
     J Clin Oncol. 2007;25:313-8.
     PubMed     Related articles    Abstract available
     
     
     
167. JACKMAN DM , Yeap BY, Lindeman NI, Fidias P, et al
     Phase II Clinical Trial of Chemotherapy-Naive Patients >= 70 Years of Age Treated With Erlotinib for Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
168. LANGER CJ
     Mind Your Elders: Therapeutic Implications of Epidermal Growth Factor Receptor Inhibition in Older Patients With Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2007;.
     PubMed     Related articles   
     
     
     
169. OZOLS RF , Herbst RS, Colson YL, Gralow J, et al
     Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
     J Clin Oncol. 2007;25:146-62.
     PubMed     Related articles    Abstract available
     
     
     December 2006
170. VERMEER-MENS JC , Goemaere NN, Kuenen-Boumeester V, de Muinck Keizer-Schrama SM, et al
     Childhood papillary thyroid carcinoma with miliary pulmonary metastases.
     J Clin Oncol. 2006;24:5788-9.
     PubMed     Related articles   
     
     
     
171. HANNA NH , Einhorn LH
     Postoperative chemotherapy for n2 non-small-cell lung cancer: conclusions are not black and white, but gray.
     J Clin Oncol. 2006;24:5611-2.
     PubMed     Related articles   
     
     
     
172. RYU JS , Lee HJ
     Effects of comorbidity and smoking on the survival of lung cancer patients.
     J Clin Oncol. 2006;24:5468-9.
     PubMed     Related articles   
     
     
     
173. ONODA S , Masuda N, Seto T, Eguchi K, et al
     Phase II Trial of Amrubicin for Treatment of Refractory or Relapsed Small-Cell Lung Cancer: Thoracic Oncology Research Group Study 0301.
     J Clin Oncol. 2006;24:5448-53.
     PubMed     Related articles    Abstract available
     
     
     
174. O'BRIEN ME , Ciuleanu TE, Tsekov H, Shparyk Y, et al
     Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer.
     J Clin Oncol. 2006;24:5441-7.
     PubMed     Related articles    Abstract available
     
     
     November 2006
175. HANNA N , Lilenbaum R, Ansari R, Lynch T, et al
     Phase II Trial of Cetuximab in Patients With Previously Treated Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2006;24:5253-8.
     PubMed     Related articles    Abstract available
     
     
     
176. SAITO H , Takada Y, Ichinose Y, Eguchi K, et al
     Phase II Study of Etoposide and Cisplatin With Concurrent Twice-Daily Thoracic Radiotherapy Followed by Irinotecan and Cisplatin in Patients With Limited-Disease Small-Cell Lung Cancer: West Japan Thoracic Oncology Group 9902.
     J Clin Oncol. 2006;24:5247-52.
     PubMed     Related articles    Abstract available
     
     
     
177. DAVIES AM , Chansky K, Lau DH, Leigh BR, et al
     Phase II Study of Consolidation Paclitaxel After Concurrent Chemoradiation in Poor-Risk Stage III Non-Small-Cell Lung Cancer: SWOG S9712.
     J Clin Oncol. 2006;24:5242-6.
     PubMed     Related articles    Abstract available
     
     
     
178. VAN SCHIL P , Stamatis G
     Sensitivity of remediastinoscopy: influence of adhesions, multilevel N2 involvement, or surgical technique?
     J Clin Oncol. 2006;24:5338.
     PubMed     Related articles   
     
     
     
179. SIEMES C , Visser LE, Coebergh JW, Splinter TA, et al
     C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
     J Clin Oncol. 2006;24:5216-22.
     PubMed     Related articles    Abstract available
     
     
     
180. TAKIGAWA N , Kiura K, Tabata M, Tanimoto M, et al
     Fractionated administration of irinotecan and Cisplatin in Japanese patients with extensive-stage-disease small-cell lung cancer.
     J Clin Oncol. 2006;24:5175.
     PubMed     Related articles   
     
     
     
181. HIRSCH FR , Varella-Garcia M, Bunn PA Jr, Franklin WA, et al
     Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
     J Clin Oncol. 2006;24:5034-42.
     PubMed     Related articles    Abstract available
     
     
     
182. FANUCCHI MP , Fossella FV, Belt R, Natale R, et al
     Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
     J Clin Oncol. 2006;24:5025-33.
     PubMed     Related articles    Abstract available
     
     
     
183. HAYES DN , Monti S, Parmigiani G, Gilks CB, et al
     Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.
     J Clin Oncol. 2006;24:5079-90.
     PubMed     Related articles    Abstract available
     
     
     October 2006
184. STINCHCOMBE TE , Socinski MA, Gangarosa LM, Khandani AH, et al
     Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan.
     J Clin Oncol. 2006;24:4939-40.
     PubMed     Related articles   
     
     
     
185. GOVINDAN R , Crowley J, Schwartzberg L, Kennedy P, et al
     Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapies.
     J Clin Oncol. 2006;24:4848-54.
     PubMed     Related articles    Abstract available
     
     
     
186. SOCINSKI MA , Weissman C, Hart LL, Beck JT, et al
     Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer.
     J Clin Oncol. 2006;24:4840-7.
     PubMed     Related articles    Abstract available
     
     
     
187. TIMMERMAN R , McGarry R, Yiannoutsos C, Papiez L, et al
     Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.
     J Clin Oncol. 2006;24:4833-9.
     PubMed     Related articles    Abstract available
     
     
     
188. LILENBAUM R , Socinski MA, Altorki NK, Hart LL, et al
     Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.
     J Clin Oncol. 2006;24:4825-32.
     PubMed     Related articles    Abstract available
     
     
     
189. PAPOTTI M , Kalebic T, Volante M, Chiusa L, et al
     Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study.
     J Clin Oncol. 2006;24:4818-24.
     PubMed     Related articles    Abstract available
     
     
     
190. MILTON DT , Riely GJ, Pao W, Miller VA, et al
     Molecular on/off switch.
     J Clin Oncol. 2006;24:4940-2.
     PubMed     Related articles   
     
     
     
191. CSIKI I , Johnson DH
     Did targeted therapy fail cyclooxygenase too?
     J Clin Oncol. 2006;24:4798-800.
     PubMed     Related articles   
     
     
     
192. GOVINDAN R , Page N, Morgensztern D, Read W, et al
     Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.
     J Clin Oncol. 2006;24:4539-44.
     PubMed     Related articles    Abstract available
     
     
     
193. ETTINGER DS , Aisner J
     Changing face of small-cell lung cancer: real and artifact.
     J Clin Oncol. 2006;24:4526-7.
     PubMed     Related articles   
     
     
     September 2006
194. PRIEST JR , Hill DA, Williams GM, Moertel CL, et al
     Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry.
     J Clin Oncol. 2006;24:4492-8.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: